Deficiencies in the activity of glucose transporters GLUT-1 and GLUT-3 (which transport glucose across the blood brain barrier) have also been found in AD [108], correlating with decreased glucose metabolism especially in areas affected by AD pathology [109]. This evidence concerns the gene SLC2A1 and Alzheimer disease.